Cost analysis for CPT J0885 — Injection, epoetin alfa, (for non-esrd use), 1000 units
Average Medicare Payment
$5.75
2023 data
Total Payments (2023)
$26.7M
Services (2023)
4.6M
Price Change (2014–2023)
-34.8%
| Year | Avg Payment | Total Payments | Services | YoY Change |
|---|---|---|---|---|
| 2014 | $8.82 | $155.2M | 17.5M | — |
| 2015 | $9.34 | $143.5M | 15.3M | +5.9% |
| 2016 | $9.58 | $140.8M | 14.6M | +2.6% |
| 2017 | $10.09 | $137.3M | 13.5M | +5.3% |
| 2018 | $9.69 | $121.5M | 12.4M | -4.0% |
| 2019 | $8.88 | $84.8M | 9.5M | -8.4% |
| 2020 | $7.65 | $45.6M | 5.9M | -13.9% |
| 2021 | $6.63 | $27.4M | 4.1M | -13.3% |
| 2022 | $6.32 | $27.1M | 4.3M | -4.7% |
| 2023 | $5.75 | $26.7M | 4.6M | -9.0% |
The most expensive state pays 1.2x more than the cheapest for this procedure. NV averages $6.22 vs RI at $5.10.
| State | Avg Payment | Total Payments | Services | Providers |
|---|---|---|---|---|
| NV | $6.22 | $13.7K | 2.2K | 1 |
| UT | $6.08 | $19.7K | 3.2K | 1 |
| KS | $6.07 | $264.8K | 43.6K | 11 |
| WI | $6.03 | $24.5K | 4.1K | 2 |
| HI | $5.98 | $60.1K | 10.0K | 3 |
| MS | $5.94 | $67.7K | 11.4K | 3 |
| IN | $5.89 | $240.7K | 40.9K | 8 |
| IA | $5.86 | $27.4K | 4.7K | 1 |
| NC | $5.86 | $486.1K | 82.9K | 48 |
| FL | $5.86 | $10.8M | 1.8M | 237 |
| NM | $5.85 | $107.4K | 18.3K | 3 |
| WA | $5.85 | $173.1K | 29.6K | 6 |
| LA | $5.85 | $78.0K | 13.3K | 2 |
| AZ | $5.84 | $626.9K | 107.3K | 72 |
| CO | $5.83 | $14.6K | 2.5K | 1 |
| AL | $5.82 | $97.0K | 16.7K | 3 |
| NE | $5.81 | $249.6K | 42.9K | 13 |
| CT | $5.81 | $154.1K | 26.6K | 6 |
| NJ | $5.80 | $1.9M | 327.3K | 66 |
| OH | $5.80 | $229.8K | 39.6K | 15 |
| AR | $5.78 | $1.6M | 275.8K | 42 |
| OK | $5.78 | $25.9K | 4.5K | 1 |
| IL | $5.77 | $288.8K | 50.1K | 21 |
| TN | $5.76 | $78.1K | 13.6K | 11 |
| VA | $5.76 | $710.4K | 123.3K | 41 |
| MD | $5.76 | $993.6K | 172.5K | 23 |
| SC | $5.76 | $511.9K | 88.9K | 24 |
| MA | $5.75 | $278.7K | 48.5K | 7 |
| OR | $5.75 | $149.3K | 26.0K | 2 |
| KY | $5.75 | $83.3K | 14.5K | 4 |
| CA | $5.74 | $2.7M | 463.7K | 103 |
| MI | $5.73 | $104.3K | 18.2K | 15 |
| PA | $5.72 | $750.8K | 131.3K | 30 |
| VT | $5.71 | $56.3K | 9.9K | 2 |
| GA | $5.69 | $690.4K | 121.3K | 26 |
| TX | $5.61 | $705.7K | 125.8K | 42 |
| NY | $5.59 | $1.3M | 238.2K | 51 |
| WV | $5.59 | $3.4K | 600 | 1 |
| MO | $5.56 | $47.2K | 8.5K | 3 |
| RI | $5.10 | $7.8K | 1.5K | 2 |
| Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| Victor Priego | Hematology-Oncology | MD | $180.4K | 31.0K | $5.82 |
| Luke Dreisbach | Hematology-Oncology | CA | $177.6K | 30.2K | $5.87 |
| Ralph Boccia | Hematology-Oncology | MD | $159.9K | 27.9K | $5.74 |
| Padmaja Sai | Hematology-Oncology | FL | $153.5K | 26.0K | $5.91 |
| Raymond Esper | Hematology-Oncology | FL | $151.2K | 25.6K | $5.91 |
| Huayang Tang | Hematology-Oncology | FL | $148.9K | 25.3K | $5.88 |
| Mohsen Thomas | Nephrology | CA | $148.4K | 25.4K | $5.84 |
| Jay Wang | Medical Oncology | FL | $148.2K | 25.0K | $5.93 |
| Manzurul Sikder | Hematology-Oncology | NY | $144.5K | 24.7K | $5.85 |
| David Wenk | Medical Oncology | FL | $139.6K | 23.6K | $5.91 |
| Steven Newman | Internal Medicine | FL | $139.5K | 23.7K | $5.89 |
| Sultana Razia | Hematology-Oncology | NY | $137.6K | 23.5K | $5.86 |
| Kewen Jauss | Hematology-Oncology | AR | $135.9K | 23.2K | $5.85 |
| Richard Buck | Medical Oncology | FL | $135.4K | 22.9K | $5.93 |
| David Wright | Hematology-Oncology | FL | $132.3K | 22.6K | $5.86 |
| Neil Kumar | Nephrology | OR | $131.9K | 22.9K | $5.75 |
| Kamal Patel | Hematology-Oncology | AR | $129.8K | 22.1K | $5.86 |
| Sunil Gandhi | Hematology-Oncology | FL | $127.7K | 21.8K | $5.87 |
| Andres Soriano | Hematology-Oncology | FL | $127.5K | 21.7K | $5.89 |
| Faithlore Gardner | Hematology-Oncology | FL | $123.4K | 21.2K | $5.82 |
Based on the data, CPT J0885 shows a 1.2x variation in pricing across states — relatively consistent by Medicare standards.
Costs have decreased 34.8% since 2014. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.
This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.